Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
about
Targeting Toll-like receptors with small molecule agentsToll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity.Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization.Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines.Toll-like receptor agonists: a patent review (2011 - 2013).Directing the immune system with chemical compounds.Immunotherapy of cancers comes of age.Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination.Interaction between TNF and BmooMP-Alpha-I, a Zinc Metalloprotease Derived from Bothrops moojeni Snake Venom, Promotes Direct Proteolysis of This Cytokine: Molecular Modeling and Docking at a Glance.A Light-Controlled TLR4 Agonist and Selectable Activation of Cell SubpopulationsEncryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells.Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control.The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein.Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 Agonists.TLR4 stimulation by LPS enhances angiogenesis in a co-culture system consisting of primary human osteoblasts and outgrowth endothelial cells.Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants.
P2860
Q26992220-BFD152AA-E467-474E-81EE-13A5FBA6BFFCQ33693637-62532B07-6200-4CBC-B6BD-3DAC3A3273EBQ34400527-6F6FDC0B-F95F-4C66-906C-AD3228263DF4Q35051389-4DE5EFC0-2770-4F60-B97C-0F171173CED8Q37045125-0C83CD46-B324-4F86-93D7-0150C1CEBB09Q38181176-DC0368C0-40C0-4ECD-BDF3-0BE10EF1CD09Q38201155-846D00B4-10E6-4411-8D39-1D320E3E040BQ40099075-02601403-C168-4E70-A3E8-D3F1998844B4Q42261896-D2CFFC43-CCD0-4E30-A6B7-AF424CC4264CQ42398393-F5E24EBA-56A7-4BEA-B33D-1BE3A7779C7CQ42758965-9F9B121F-1F10-43F0-8DCD-ADF4557FFB85Q47114921-97CCF344-D65D-49D0-A2BE-672BF3B73162Q47135299-F193B2B2-76FD-4715-A0DA-E22EB3DC02B9Q47147061-1B50448C-21BE-48DE-A87F-389F31C87226Q47551575-F2B0F094-8EF8-4E83-99C9-66558804B613Q50533018-236FE5D8-41EF-4AE5-8511-6ADD2A48A0FDQ51836448-BEEA51EE-4343-4B57-AD8D-4E01861C1C48Q55517783-78D2C35E-D3E2-4111-8DFA-21F4684240BC
P2860
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@ast
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@en
Synthetic Toll like receptor-4
@nl
type
label
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@ast
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@en
Synthetic Toll like receptor-4
@nl
prefLabel
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@ast
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@en
Synthetic Toll like receptor-4
@nl
P2093
P2860
P1433
P1476
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
@en
P2093
Abraham Mittelman
Andrea L George
Arulkumaran Shanmugam
Raj K Tiwari
Robert Suriano
Shilpi Rajoria
P2860
P304
P356
10.1371/JOURNAL.PONE.0030839
P407
P577
2012-02-20T00:00:00Z